Xylocaine
- Product NDC
- 63323-485
- Requested package NDC
- 63323-485-27
- 11-digit product format
- 633230485
- Labeler code
- 63323
- Product ID
- 63323-485_0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LIDOCAINE HYDROCHLORIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INFILTRATION; PERINEURAL
- Labeler
- Fresenius Kabi USA, LLC
- Application
- NDA006488
- Marketing category
- NDA
- Marketing start
- 2010-08-12
- Substance
- LIDOCAINE HYDROCHLORIDE ANHYDROUS
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N006488-002 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 2% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N006488-003 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.01MG/ML;2% | INJECTABLE / INJECTION | RLD, Approved before 1982 | ||
| N006488-004 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.01MG/ML;1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N006488-005 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.02MG/ML;2% | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | ||
| N006488-007 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N006488-008 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N006488-010 | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N006488-012 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N006488-017 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N006488-018 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;1% | INJECTABLE / INJECTION | RLD, RS | 1986-11-13 | |
| N006488-019 | XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | 0.005MG/ML;2% | INJECTABLE / INJECTION | AP | RLD, RS | 1986-11-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N006488-002 | AP |
| N006488-004 | AP |
| N006488-007 | AP |
| N006488-008 | AP |
| N006488-010 | AP |
| N006488-012 | AP |
| N006488-017 | AP |
| N006488-019 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N006488-002 | XYLOCAINE | 2% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-003 | XYLOCAINE W/ EPINEPHRINE | 0.01MG/ML;2% | INJECTABLE / INJECTION | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N006488-004 | XYLOCAINE W/ EPINEPHRINE | 0.01MG/ML;1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-005 | XYLOCAINE W/ EPINEPHRINE | 0.02MG/ML;2% | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N006488-007 | XYLOCAINE | 1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-008 | XYLOCAINE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-010 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-012 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-017 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-018 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | RLD, RS | 1986-11-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-019 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | AP | RLD, RS | 1986-11-13 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-002 | XYLOCAINE | 2% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-003 | XYLOCAINE W/ EPINEPHRINE | 0.01MG/ML;2% | INJECTABLE / INJECTION | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-004 | XYLOCAINE W/ EPINEPHRINE | 0.01MG/ML;1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-005 | XYLOCAINE W/ EPINEPHRINE | 0.02MG/ML;2% | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-007 | XYLOCAINE | 1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-008 | XYLOCAINE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-010 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-012 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-017 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-018 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | RLD, RS | 1986-11-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-019 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | AP | RLD, RS | 1986-11-13 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-002 | XYLOCAINE | 2% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-003 | XYLOCAINE W/ EPINEPHRINE | 0.01MG/ML;2% | INJECTABLE / INJECTION | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N006488-004 | XYLOCAINE W/ EPINEPHRINE | 0.01MG/ML;1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-005 | XYLOCAINE W/ EPINEPHRINE | 0.02MG/ML;2% | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N006488-007 | XYLOCAINE | 1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-008 | XYLOCAINE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-010 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-012 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-017 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-018 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;1% | INJECTABLE / INJECTION | RLD, RS | 1986-11-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-019 | XYLOCAINE W/ EPINEPHRINE | 0.005MG/ML;2% | INJECTABLE / INJECTION | AP | RLD, RS | 1986-11-13 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-002 | XYLOCAINE | 2% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-003 | XYLOCAINE W/ EPINEPHRINE | 0.01MG/ML;2% | INJECTABLE / INJECTION | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-004 | XYLOCAINE W/ EPINEPHRINE | 0.01MG/ML;1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-005 | XYLOCAINE W/ EPINEPHRINE | 0.02MG/ML;2% | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-007 | XYLOCAINE | 1% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-008 | XYLOCAINE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-010 | XYLOCAINE | 1.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N006488-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-004 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-007 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-008 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-010 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-012 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-017 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N006488-019 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-004 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-007 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-008 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-010 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-012 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-017 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006488-019 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-004 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-007 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-008 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-010 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-012 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-017 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N006488-019 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-004 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-007 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-008 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-010 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-012 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-017 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006488-019 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006488-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006488-004 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006488-007 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006488-008 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006488-010 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006488-012 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006488-017 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006488-019 | AP | 1 | b8a1b40f171c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Xylocaine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE ANHYDROUS | 10 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| EC2CNF7XFP | Internal UNII lookup |
| 30Q7KI53AK | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1010033 | Internal RxNorm lookup |
| 1010035 | Internal RxNorm lookup |
| 1010671 | Internal RxNorm lookup |
| 1010673 | Internal RxNorm lookup |
| 1010751 | Internal RxNorm lookup |
| 1010755 | Internal RxNorm lookup |
| 1737562 | Internal RxNorm lookup |
| 1737563 | Internal RxNorm lookup |
| 1737566 | Internal RxNorm lookup |
| 1737567 | Internal RxNorm lookup |
| 1737568 | Internal RxNorm lookup |
| 1737569 | Internal RxNorm lookup |
| 1737570 | Internal RxNorm lookup |
| 1737571 | Internal RxNorm lookup |
| 1737757 | Internal RxNorm lookup |
| 1737758 | Internal RxNorm lookup |
| 1737761 | Internal RxNorm lookup |
| 1737762 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4dd52202-8eef-4136-92dd-ada573b7cf74 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-485-01 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-485-03 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-485-27 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-485-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-485-26 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-485-41 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-485-01 | ML - Milliliter | 63323-485 | 55c3520d-d402-4267-87fe-ec239a7384ea | 1 | 2019-12-10 |
| 63323-485-03 | ML - Milliliter | 63323-485 | 8152cfd7-4dd8-49cd-8f86-c8e56a346d48 | 1 | 2019-12-10 |
| 63323-485-26 | ML - Milliliter | 63323-485 | 2b9ff4f4-641e-4bb5-9378-b0f143bdac48 | 1 | 2016-09-02 |
| 63323-485-27 | ML - Milliliter | 63323-485 | 84d0434d-5c06-4795-baaa-4cf67cf1a8e9 | 1 | 2012-07-24 |
| 63323-485-41 | ML - Milliliter | 63323-485 | 7ad5e0f1-7fc8-4e2c-949a-b8a6bf1a6808 | 1 | 2020-07-13 |
| 63323-485-57 | ML - Milliliter | 63323-485 | fcef2f79-20f4-4731-a3c6-7c153a2919bb | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-485 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 4 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-485 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xylocaine MPF | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 50aa6133-0776-4714-9821-fe8581f635ca | 2026-07-28 | Warnings, Adverse reactions | 006488 NDA006488 |
| XYLOCAINE-MPF WITH EPI | XYLOCAINE-MPF WITH EPI | HF Acquisition Co LLC, DBA HealthFirst | c5dcb0e5-2624-9c9c-e053-2995a90a6d65 | 2026-06-19 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Sportpharm LLC | 74bad838-2800-4d36-a3ee-cc1d739d24c2 | 2026-03-21 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 94155012-b1fc-430a-a1f5-30c21f4a3f80 | 2026-02-03 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | 27c2e78d-d037-470d-b4fa-44c33d78f788 | 2025-11-07 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | 6899113c-dee4-4227-9f68-475fcce6b91e | 2025-11-07 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | cfcc8a07-b40c-476d-9a21-83487318ac85 | 2025-11-07 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | ffc87dfb-0e26-4b42-80fd-3fb7690119e3 | 2025-11-07 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HCL | Henry Schein, Inc. | a6019956-a6e0-4988-a870-6aee06c354c3 | 2025-11-07 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | REMEDYREPACK INC. | 1414bcfc-1543-4ad4-83bd-4fc444a02e92 | 2025-10-09 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE INJECTION, SOLUTION | Henry Schein, Inc | 9e8d0318-b2fe-4084-aedf-de97f61605a8 | 2025-08-07 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | ProPharma Distribution | 386c23fd-1691-98b2-e063-6294a90ab070 | 2025-07-18 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 25370b0f-0ac6-4a03-abe6-d73d65192180 | 2025-05-31 | Warnings, Adverse reactions | 006488 NDA006488 |
| XYLOCAIN (LIDOCAINE HCl ) | XYLOCAINE (LIDOCAINE HCL ) | HF Acquisition Co LLC, DBA HealthFirst | e1838a93-7f2a-14f1-e053-2a95a90a8d69 | 2025-05-07 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | 4dd52202-8eef-4136-92dd-ada573b7cf74 | 2025-04-22 | Warnings, Adverse reactions | 006488 NDA006488 63323-485 |
| XYLOCAINE MPF | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 1986c302-82a0-95a9-e063-6294a90a3339 | 2024-11-15 | Warnings, Adverse reactions | 006488 NDA006488 |
| XYLOCAINE MPF | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 199ac3eb-1fa5-9cf5-e063-6394a90a7228 | 2024-11-15 | Warnings, Adverse reactions | 006488 NDA006488 |
| XYLOCAINE | XYLOCAINE | HF Acquisition Co LLC, DBA HealthFirst | 17e77013-f2a0-b1f7-e063-6294a90ae468 | 2024-05-29 | Warnings, Adverse reactions | 006488 NDA006488 |
| XYLOCAINE MPF | XYLOCAINE MPF | HF Acquisition Co LLC, DBA HealthFirst | 18705416-9593-43f2-e063-6294a90a31b4 | 2024-05-14 | Warnings, Adverse reactions | 006488 NDA006488 |
| Xylocaine MPF | LIDOCAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | d5e0d06f-ba1e-44d4-aa89-39d6c146dc23 | 2024-05-13 | Warnings, Adverse reactions | 006488 NDA006488 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1010745 | lidocaine HCl 0.5 % / EPINEPHrine 1:200,000 Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737343 | lidocaine HCl 0.5 % in 50 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010900 | lidocaine HCl 0.5 % Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010751 | lidocaine HCl 1 % / EPINEPHrine 1:100,000 Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867938 | lidocaine HCl 1 % / EPINEPHrine 1:200,000 in 10 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867943 | lidocaine HCl 1 % / EPINEPHrine 1:200,000 in 30 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737570 | lidocaine HCl 1 % in 10 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737568 | lidocaine HCl 1 % in 2 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737562 | lidocaine HCl 1 % in 30 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737566 | lidocaine HCl 1 % in 5 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010033 | lidocaine HCl 1 % Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867992 | lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 in 10 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867996 | lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 in 30 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010759 | lidocaine HCl 2 % / EPINEPHrine 1:100,000 Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1868028 | lidocaine HCl 2 % / EPINEPHrine 1:200,000 in 10 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010688 | lidocaine HCl 2 % / EPINEPHrine 1:200,000 in 20 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737757 | lidocaine HCl 2 % in 2 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737761 | lidocaine HCl 2 % in 5 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010671 | lidocaine HCl 2 % Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010749 | Xylocaine 0.5 % / EPINEPHrine 1:200,000 Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737345 | Xylocaine 0.5 % in 50 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010902 | Xylocaine 0.5 % Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010755 | Xylocaine 1 % / EPINEPHrine 1:100,000 Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867940 | Xylocaine 1 % / EPINEPHrine 1:200,000 in 10 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867944 | Xylocaine 1 % / EPINEPHrine 1:200,000 in 30 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737571 | Xylocaine 1 % in 10 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737569 | Xylocaine 1 % in 2 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737563 | Xylocaine 1 % in 30 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737567 | Xylocaine 1 % in 5 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010035 | Xylocaine 1 % Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867993 | Xylocaine 1.5 % / EPINEPHrine 1:200,000 in 10 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867997 | Xylocaine 1.5 % / EPINEPHrine 1:200,000 in 30 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010763 | Xylocaine 2 % / EPINEPHrine 1:100,000 Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1868029 | Xylocaine 2 % / EPINEPHrine 1:200,000 in 10 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010692 | Xylocaine 2 % / EPINEPHrine 1:200,000 in 20 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737758 | Xylocaine 2 % in 2 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737762 | Xylocaine 2 % in 5 ML Injection | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010673 | Xylocaine 2 % Injectable Solution | PSN | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867940 | 10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 10 MG/ML Injection [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867993 | 10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1868029 | 10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737571 | 10 ML lidocaine hydrochloride 10 MG/ML Injection [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737569 | 2 ML lidocaine hydrochloride 10 MG/ML Injection [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737758 | 2 ML lidocaine hydrochloride 20 MG/ML Injection [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010692 | 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867944 | 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 10 MG/ML Injection [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867997 | 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737563 | 30 ML lidocaine hydrochloride 10 MG/ML Injection [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737567 | 5 ML lidocaine hydrochloride 10 MG/ML Injection [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737762 | 5 ML lidocaine hydrochloride 20 MG/ML Injection [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737345 | 50 ML lidocaine hydrochloride 5 MG/ML Injection [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010749 | epinephrine 0.005 MG/ML / lidocaine hydrochloride 5 MG/ML Injectable Solution [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010755 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010763 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Injectable Solution [Xylocaine with Epinephrine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010035 | lidocaine hydrochloride 10 MG/ML Injectable Solution [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010673 | lidocaine hydrochloride 20 MG/ML Injectable Solution [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010902 | lidocaine hydrochloride 5 MG/ML Injectable Solution [Xylocaine] | SBD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867938 | 10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 10 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867992 | 10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1868028 | 10 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737570 | 10 ML lidocaine hydrochloride 10 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737568 | 2 ML lidocaine hydrochloride 10 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737757 | 2 ML lidocaine hydrochloride 20 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010688 | 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867943 | 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 10 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1867996 | 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737562 | 30 ML lidocaine hydrochloride 10 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737566 | 5 ML lidocaine hydrochloride 10 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737761 | 5 ML lidocaine hydrochloride 20 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737343 | 50 ML lidocaine hydrochloride 5 MG/ML Injection | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010745 | epinephrine 0.005 MG/ML / lidocaine hydrochloride 5 MG/ML Injectable Solution | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010751 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010759 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Injectable Solution | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010033 | lidocaine hydrochloride 10 MG/ML Injectable Solution | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010671 | lidocaine hydrochloride 20 MG/ML Injectable Solution | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1010900 | lidocaine hydrochloride 5 MG/ML Injectable Solution | SCD | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737571 | 10 ML Xylocaine 10 MG/ML Injection | SY | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737569 | 2 ML Xylocaine 10 MG/ML Injection | SY | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737758 | 2 ML Xylocaine 20 MG/ML Injection | SY | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
| 1737563 | 30 ML Xylocaine 10 MG/ML Injection | SY | ba082c2f-64f4-419d-9c88-74f203316e17 | 13 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63323-485-27 | 63323048527 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-485-27) / 20 mL in 1 VIAL, MULTI-DOSE (63323-485-01) | 2010-08-12 | 0000-00-00 | No | No | Current |